Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Collegium Pharmaceutical
Collegium Pharmaceutical
(COLL)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Nucynta
Tapentadol
2008-11-20
2024-2028
Pain
Xtampza
Oxycodone
2016-04-26
2024-2036
Pain
,
Fever
,
Postoperative pain
,
Alcoholism
,
Opioid-related disorders
,
Drug overdose
,
Juvenile arthritis
,
Menorrhagia
,
Ankylosing spondylitis
,
Rheumatoid arthritis
,
Inflammation
,
Osteoarthritis
,
Bursitis
,
Dysmenorrhea
,
Gout
,
Premenstrual syndrome
,
Rheumatic fever
,
Septic shock
,
Respiration disorders
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Oxycodone
neuralgia
,
healthy volunteers/patients
,
multiple sclerosis
,
chronic pain
,
sclerosis
,
nociceptive pain
,
chest pain
,
pain
Aspartame
prostatic hyperplasia
,
healthy volunteers/patients
,
respiratory tract diseases
,
respiration disorders
,
hyperhidrosis
,
kidney diseases
,
obesity
,
weight loss
,
burns
,
bronchiectasis
,
respiratory tract infections
,
skin diseases
,
premature obstetric labor
,
heart failure
,
pulmonary edema
,
amyloidosis
,
bacterial infections
,
liver diseases
,
hepatic insufficiency
,
sepsis
,
non-alcoholic fatty liver disease
,
neoplasms
,
multiple myeloma
,
common cold
,
tuberculosis
,
recurrence
,
breast neoplasms
,
rhinitis
,
pulmonary tuberculosis
,
atherosclerosis
,
obstructive lung diseases
,
plasma cell neoplasms
,
virus diseases
,
pancreatic neoplasms
,
lymphoma
,
follicular lymphoma
,
allergic rhinitis
,
coronary disease
,
coronary artery disease
,
myocardial ischemia
,
heart diseases
,
carcinoma
,
hepatocellular carcinoma
,
liver neoplasms
,
precursor cell lymphoblastic leukemia-lymphoma
,
precursor t-cell lymphoblastic leukemia-lymphoma
,
sjogren's syndrome
,
xerostomia
,
ulcer
,
buruli ulcer
,
hiv infections
,
systemic lupus erythematosus
,
malaria
,
infections
,
acquired immunodeficiency syndrome
,
vivax malaria
,
type 2 diabetes mellitus
,
human influenza
,
communicable diseases
,
hemolysis
,
bone fractures
,
parkinson disease
,
pemphigus
,
migraine disorders
,
depression
,
major depressive disorder
,
depressive disorder
,
churg-strauss syndrome
,
granulomatosis with polyangiitis
,
systemic vasculitis
,
eosinophilic granuloma
,
neisseria meningitidis
,
haemophilus influenzae type b
,
restless legs syndrome
,
psychomotor agitation
,
syndrome
,
hypereosinophilic syndrome
,
covid-19
,
arthralgia
,
ovarian neoplasms
,
ovarian epithelial carcinoma
,
anthrax
,
urinary tract infections
,
pyelonephritis
,
respiratory syncytial virus infections
,
asthma
,
chronic obstructive pulmonary disease
,
lung diseases
,
diabetes mellitus
,
hepatitis
,
hepatitis a
,
nausea
,
pulmonary eosinophilia
,
prostatic neoplasms
,
autoimmune diseases
,
hyperplasia
,
growth and development
,
neuralgia
,
herpes zoster
,
postherpetic neuralgia
,
herpes simplex
Phenylacetic acid
healthy volunteers/patients
,
knee osteoarthritis
,
hip osteoarthritis
,
actinic keratosis
,
keratosis
Hld200
attention deficit disorder with hyperactivity
,
hyperkinesis
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use